Novo Nordisk A/S (NVO)
NYSE: NVO · Real-Time Price · USD
48.17
+1.81 (3.90%)
Dec 10, 2025, 12:18 PM EST - Market open
Novo Nordisk (NVO) Revenue by Segment
History
| Date | Diabetes | Obesity | Rare Disease |
|---|---|---|---|
| Jun 30, 2025 | 33.24B | 12.32B | 3.09B |
| Mar 31, 2025 | 33.02B | 11.31B | 2.94B |
| Dec 31, 2024 | 32.22B | 10.16B | 2.91B |
| Sep 30, 2024 | 30.89B | 8.57B | 2.73B |
| Jun 30, 2024 | 30.06B | 7.55B | 2.63B |
| Mar 31, 2024 | 28.45B | 6.99B | 2.65B |
| Dec 31, 2023 | 27.05B | 6.49B | 2.68B |
| Sep 30, 2023 | 25.13B | 5.60B | 2.72B |
| Jun 30, 2023 | 24.13B | 4.36B | 2.91B |
| Mar 31, 2023 | 22.96B | 3.32B | 3.08B |
| Dec 31, 2022 | 21.76B | 2.63B | 3.20B |
| Sep 30, 2022 | 20.73B | 2.16B | 3.18B |
| Jun 30, 2022 | 19.58B | 1.86B | 3.09B |
| Mar 31, 2022 | 18.59B | 1.60B | 3.05B |
| Dec 31, 2021 | 17.65B | 1.31B | 2.99B |
| Sep 30, 2021 | 16.47B | 1.12B | 2.96B |
| Jun 30, 2021 | 15.70B | 969.37M | 3.00B |
| Mar 31, 2021 | 15.39B | 883.60M | 2.97B |
| Dec 31, 2020 | 15.15B | 885.63M | 2.99B |
| Sep 30, 2020 | 15.68B | 942.71M | 3.12B |
Source: Business metrics provided by Main Street Data and sourced
from official company press releases and documents.